Letter to the editor: comment on “Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment”
Medical Oncology · 2024
DOI: 10.1007/s12032-024-02487-2 ↗Kurz gefasst
Leserbrief in der Zeitschrift Medical Oncology, 2024. Verfasst von Murali Santhoshkumar. Beteiligte Einrichtung: Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha Un…. Hauptthemen laut MEDLINE: Liver Neoplasms, TOR Serine-Threonine Kinases, Matrix Metalloproteinase 9, Metal Nanoparticles. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, India. santhoshmurali2494@gmail.com.
Zitieren
APA
Santhoshkumar, M. (2024). Letter to the editor: comment on “Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment”. Medical Oncology. https://doi.org/10.1007/s12032-024-02487-2
Vancouver
Santhoshkumar M. Letter to the editor: comment on “Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment”. Medical Oncology. 2024. doi:10.1007/s12032-024-02487-2
BibTeX
@article{Santhoshkumar2024,
author = {Santhoshkumar, Murali},
title = {Letter to the editor: comment on “Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment”},
journal = {Medical Oncology},
year = {2024},
doi = {10.1007/s12032-024-02487-2}
}
EUVIMED